BIOGEN PHARMACEUTICAL CO.
About BIOGEN PHARMACEUTICAL CO.
Categories
-
IN -
2022On CPHI since
Company types
Products from BIOGEN PHARMACEUTICAL CO. (1)
-
Product azithromycin 500 mg
azithromycin 500 mg USP
BIOGEN PHARMACEUTICAL CO. Resources (1)
-
News Biogen receives accelerated approval for first-of-its-kind ALS treatment
Biogen has announced that they have received approval from the US FDA for the amyotrophic lateral sclerosis (ALS) treatment, QALSODY™ (tofersen). This is the first approval of a treatment that targets a genetic cause of ALS.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance